Indisulam (E7070) 10mg 10mg | Purity Not Available
Adooq Bioscience
Indisulam (E7070) is a carbonic anhydrase inhbitor, is also a novel synthetic sulfon-amide that targets the G1 phase of the cell cycle.
More Information Supplier PageIndisulam (E7070) is a carbonic anhydrase inhbitor, is also a novel synthetic sulfon-amide that targets the G1 phase of the cell cycle.
More Information Supplier PageElacridaris a prototypical BCRP inhibitor which inhibits the Bcrp1-mediated transport.
More Information Supplier PageElacridaris a prototypical BCRP inhibitor which inhibits the Bcrp1-mediated transport.
More Information Supplier PageElacridaris a prototypical BCRP inhibitor which inhibits the Bcrp1-mediated transport.
More Information Supplier PageElacridaris a prototypical BCRP inhibitor which inhibits the Bcrp1-mediated transport.
More Information Supplier PageEfaproxiral increases oxygen levels in hypoxic tumor tissues by binding non-covalently to the hemoglobin tetramer and decreasing hemoglobin-oxygen binding affinity.
More Information Supplier PageEfaproxiral increases oxygen levels in hypoxic tumor tissues by binding non-covalently to the hemoglobin tetramer and decreasing hemoglobin-oxygen binding affinity.
More Information Supplier PageEfaproxiral increases oxygen levels in hypoxic tumor tissues by binding non-covalently to the hemoglobin tetramer and decreasing hemoglobin-oxygen binding affinity.
More Information Supplier PageEfaproxiral increases oxygen levels in hypoxic tumor tissues by binding non-covalently to the hemoglobin tetramer and decreasing hemoglobin-oxygen binding affinity.
More Information Supplier PageAstragaloside I, II, III, and IV concentration-dependently increased the CD45-mediated of pNPP/OMFP hydrolysis with the EC50 values ranged from 3.33 to 10.42 ug/mL.
More Information Supplier Page